Literature DB >> 18290999

Epidemiology of meningococcal disease in southern Brazil from 1995 to 2003, and molecular characterization of Neisseria meningitidis using multilocus sequence typing.

L F Baethgen1, L Weidlich, C Moraes, C Klein, L S Nunes, P I Cafrune, A P Lemos, S S Rios, M F Abreu, C Kmetzsch, A F Sperb, L W Riley, M L R Rossetti, A Zaha.   

Abstract

OBJECTIVE: To describe the epidemiology of meningococcal disease (MD) in southern Brazil.
METHODS: Retrospective cohort study among 2215 MD cases reported from 1995 to 2003 in Rio Grande do Sul (RS) State.
RESULTS: The overall incidence fell by 50%; the case-fatality rate during this period was 22%. Even so, the incidence of MD remained high after the epidemic period ended in 1999. Together, the age groups of 1-4 years and infants accounted for 54.1% of reported cases with incidences of 11.3/100 000 and 31.3/100 000, respectively; 69.8% of cases were caused by Neisseria meningitidis serogroup B, which increased significantly. There was a significant decrease in serogroup C cases in the whole period. The phenotypes B:4,7:P1.19,15, B:15:P1.7,16 and B:NT:P1.3 caused almost 50% of all serotyped cases. Fifty-six isolates obtained from RS patients during the first non-epidemic year 2000 plus 20 isolates from other southern Brazilian states (Santa Catarina and Paraná), Denmark and France were typed by multilocus sequence typing. Twenty sequence types (STs) were identified, eight of them found only in RS. ST-33 (27%) and ST-259 (18%) were the most frequent; both belong to the ST-32/ET-5 complex. ST-259 cases showed a trend towards higher risk of fatal outcome. ST-259 isolates were not detected among geographic controls or in other studies in Brazil.
CONCLUSION: Our data suggest that ST-33 and ST-259 clones and the emergence of the ST-103 isolates contributed to the continued high incidence of MD in RS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18290999     DOI: 10.1111/j.1365-3156.2007.01970.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  9 in total

Review 1.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

2.  Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.

Authors:  Yanet Climent; Daniel Yero; Isabel Martinez; Alejandro Martín; Keith A Jolley; Franklin Sotolongo; Martin C J Maiden; Rachel Urwin; Rolando Pajón
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

Review 3.  The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape.

Authors:  M A P Sáfadi; S González-Ayala; A Jäkel; H Wieffer; C Moreno; A Vyse
Journal:  Epidemiol Infect       Date:  2012-08-09       Impact factor: 2.451

4.  Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.

Authors:  Ivano de Filippis; Ana Paula S de Lemos; Jessica B Hostetler; Kurt Wollenberg; Claudio T Sacchi; Julie C Dunning Hotopp; Lee H Harrison; Margaret C Bash; D Rebecca Prevots
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

5.  Development of a multiple cross displacement amplification combined with nanoparticles-based biosensor assay to detect Neisseria meningitidis.

Authors:  Shijun Li; Chunting Liu; Ying Liu; Qing Ma; Yue Wang; Yi Wang
Journal:  Infect Drug Resist       Date:  2019-07-15       Impact factor: 4.003

6.  Construction of Opa-positive and Opa-negative strains of Neisseria meningitidis to evaluate a novel meningococcal vaccine.

Authors:  Manish Sadarangani; J Claire Hoe; Martin J Callaghan; Claire Jones; Hannah Chan; Katherine Makepeace; Hélène Daniels-Treffandier; Mary E Deadman; Christopher Bayliss; Ian Feavers; Peter van der Ley; Andrew J Pollard
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

7.  Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells.

Authors:  Claire Jones; Manish Sadarangani; Susan Lewis; Isabelle Payne; Muhammad Saleem; Jeremy P Derrick; Andrew J Pollard
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

8.  A cross-sectional study assessing the pharyngeal carriage of Neisseria meningitidis in subjects aged 1-24 years in the city of Embu das Artes, São Paulo, Brazil.

Authors:  Lily Yin Weckx; Rosana Fiorini Puccini; Antónia Machado; Maria Gisele Gonçalves; Suely Tuboi; Eliana de Barros; Raghavendra Devadiga; Eduardo Ortega-Barria; Romulo Colindres
Journal:  Braz J Infect Dis       Date:  2017-07-14       Impact factor: 3.257

9.  Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil.

Authors:  Márcia de Cantuária Tauil; Cleidiane Santos Rodrigues de Carvalho; Ataiza César Vieira; Eliseu Alves Waldman
Journal:  Braz J Infect Dis       Date:  2014-03-31       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.